CS logo
small CS logo
Derma-Study-Center Friedrichshafen GmbH

Friedrichshafen, Germany
Studying center in Friedrichshafen, Baden-Württemberg
Charlottenstraße 12/1, 88045 Friedrichshafen

About Derma-Study-Center Friedrichshafen GmbH


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
LEO Pharma
3
Amgen
2
Incyte Corporation
2
Janssen Research & Development, LLC
2
Journey Medical Corporation
2
Eli Lilly and Company
1
Janssen-Cilag G.m.b.H
1
UNION therapeutics
1
Total Rows: 8

Clinical Trials at Derma-Study-Center Friedrichshafen GmbH


During the past decade, Derma-Study-Center Friedrichshafen GmbH conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 5 clinical trials were completed, i.e. on average, 38.5% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 3 clinical trials were completed. i.e. 42.9% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years220022002200332222000000220022001100Started TrialsCompleted Trails20152016201720182019202020212022202301234
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis
2005-05-25
2019-01-31
Terminated
8,071
Study of Glycopyrronium in Axillary Hyperhydrosis
2015-07-01
2016-03-01
Completed
344
Long-term Safety Study of Glycopyrronium in Subjects With Primary Axillary Hyperhidrosis
2015-08-01
2016-12-01
Completed
564
Tralokinumab Monotherapy for Moderate to Severe Atopic Dermatitis - ECZTRA 1 (ECZema TRAlokinumab Trial no. 1)
2017-05-30
2019-10-10
Completed
802
A Trial Comparing the Efficacy of Subcutaneous Injections of Brodalumab to Oral Administrations of Fumaric Acid Esters in Adults With Moderate to Severe Plaque Psoriasis
2017-11-03
2019-03-21
Completed
210
A Study to Evaluate Further Therapeutic Strategies With Guselkumab in Participants With Moderate-to-Severe Plaque-Type Psoriasis
2019-02-08
2025-01-30
Active, not recruiting
880
Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate to Severe Atopic Dermatitis
2019-10-29
2022-04-28
Completed
445
A Study to Investigate Interchangeability of ABP 654 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis
2021-03-24
2023-02-28
Completed
494

Rows per page:

1–14 of 14

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Derma-Study-Center Friedrichshafen GmbH" #1 sponsor was "LEO Pharma" with 3 trials, followed by "Amgen" with 2 trials sponsored, "Incyte Corporation" with 2 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored and "Journey Medical Corporation" with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Derma-Study-Center Friedrichshafen GmbH" #1 collaborator was "Dermira, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.
Created with Highcharts 11.1.0Top Leading SponsorsLEO Pharma: 3LEO Pharma: 3Amgen: 2Amgen: 2Incyte Corporation: 2Incyte Corporation: 2Janssen Research &Development, LLC: 2Janssen Research &Development, LLC: 2Journey Medical Corporation: 2Journey Medical Corporation: 2Eli Lilly and Company: 1Eli Lilly and Company: 1Janssen-Cilag G.m.b.H: 1Janssen-Cilag G.m.b.H: 1UNION therapeutics: 1UNION therapeutics: 1

Created with Highcharts 11.1.0Top CollaboratorsDermira, Inc.: 1Dermira, Inc.: 1

Clinical Trials Conditions at Derma-Study-Center Friedrichshafen GmbH


According to Clinical.Site data, the most researched conditions in "Derma-Study-Center Friedrichshafen GmbH" are "Atopic Dermatitis" (3 trials), "Plaque Psoriasis" (3 trials), "Psoriasis" (3 trials), "Hyperhidrosis" (2 trials) and "Chronic Hand Eczema (CHE)" (1 trials). Many other conditions were trialed in "Derma-Study-Center Friedrichshafen GmbH" in a lesser frequency.

Clinical Trials Intervention Types at Derma-Study-Center Friedrichshafen GmbH


Most popular intervention types in "Derma-Study-Center Friedrichshafen GmbH" are "Drug" (12 trials), "Biological" (2 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "Vehicle" (3 trials), "JNJ-77242113" (2 trials), "Ruxolitinib cream" (2 trials) and "ABP 501" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Derma-Study-Center Friedrichshafen GmbH


The vast majority of trials in "Derma-Study-Center Friedrichshafen GmbH" are 14 trials for "All" genders.

Clinical Trials Status at Derma-Study-Center Friedrichshafen GmbH


Currently, there are NaN active trials in "Derma-Study-Center Friedrichshafen GmbH". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Derma-Study-Center Friedrichshafen GmbH, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Derma-Study-Center Friedrichshafen GmbH, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 9Phase 3: 9Phase 2: 3Phase 2: 3Phase 4: 1Phase 4: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 9Completed: 9Withdrawn: 2Withdrawn: 2Active, not recruiting: 1Active, not recruiting: 1Recruiting: 1Recruiting: 1Terminated: 1Terminated: 1